Key result
Type 2 diabetes mellitus was associated with significantly lower mean FEV (1.98 vs 2.09, p=0.033) and FVC (2.35 vs 2.53, p=0.045) compared to matched healthy controls.
Why the study?
Diabetes mellitus hampers pulmonary functions, prompting the study to estimate spirometric indices in patients with type 2 diabetes mellitus.
Are spirometric indices reduced in patients with type 2 diabetes mellitus compared to healthy controls?
Cross-Sectional (n=146)
No
Are spirometric indices reduced in patients with type 2 diabetes mellitus compared to healthy controls?
Type 2 diabetes mellitus is associated with a significant decrease in spirometric indices, suggesting pulmonary function should be monitored in these patients.
Background: Diabetes mellitus is a non-communicable disease of global health importance. It is a metabolic disorder caused by increased levels of blood glucose over a prolonged period of time. Type 2 diabetes mellitus (T2DM) is usually associated with obesity and insulin resistance. Several studies have also revealed that diabetes mellitus hampers pulmonary functions. This study was aimed at estimating the spirometric indices in type 2 diabetes mellitus patients. Methods: A cross-sectional study of T2DM patients and apparently healthy control attending the medical outpatient clinic in a tertiary institution in south western Nigeria. Results: A total of 146 participants with 73 patients with T2DM and 73 control groups. There were no significant differences in the age, body mass index, and gender distribution of the diabetics and control. However, patients with diabetes had higher SBP (133.2±20.17 mmHg vs 111.6±6.5 mmHg p<0.0001), and DBP (78.4±11.8mmHg vs 73.7±6.3 mmHg, p=0.003) when compared to the control. The mean FEV (1.98±0.5 vs 2.09±1.2, p=0.033), FVC (2.35±0.6 vs 2.53±1.3, p=0.045) and FEV/FVC ratio (83.61±7.2 vs 81.14±10.7, p=0.029) were significantly lower in diabetic patients when compared to matched controls. There was no significant difference in the PEF and FEF of both groups. Conclusion: Type 2 diabetes mellitus patients had significant decrease in their spirometric indices, hence pulmonary function should be included in the periodic comprehensive diabetic check for holistic management.
No takes yet. Share an insight, caveat, or question.
Adeoti et al. (2021) conducted a cross-sectional in Type 2 diabetes mellitus (n=146). Type 2 diabetes mellitus vs. Apparently healthy controls was evaluated on Mean FEV (p=0.033). Type 2 diabetes mellitus was associated with significantly lower mean FEV (1.98 vs 2.09, p=0.033) and FVC (2.35 vs 2.53, p=0.045) compared to matched healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: